Compare STN & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STN | RVTY |
|---|---|---|
| Founded | 1954 | 1937 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 11.8B |
| IPO Year | 2005 | 1994 |
| Metric | STN | RVTY |
|---|---|---|
| Price | $88.86 | $86.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 16 |
| Target Price | ★ $175.00 | $109.67 |
| AVG Volume (30 Days) | 212.8K | ★ 800.6K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.74% | 0.30% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $11.06 | $6.37 |
| Revenue Next Year | $6.61 | $5.10 |
| P/E Ratio | ★ $28.96 | $45.82 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $84.08 | $81.36 |
| 52 Week High | $114.52 | $118.30 |
| Indicator | STN | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 48.97 | 41.96 |
| Support Level | $84.76 | $83.22 |
| Resistance Level | $96.29 | $88.60 |
| Average True Range (ATR) | 2.15 | 3.20 |
| MACD | 0.37 | 0.31 |
| Stochastic Oscillator | 48.52 | 29.76 |
Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.